TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT05587569: Outcomes Following Combined Adductoplasty™ and Lapiplasty® (MTA3D)

Sponsor: Treace Medical Concepts, Inc. · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 80 pts

Competing Trials Overlap

7 Active Trials

Excess Burn Exposure

$1,261,600

Rescue Site Savings

+$830,000

Unlock Full NCT05587569 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05587569 Rescue Dossier →